Compare NRXP & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRXP | RFM |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | 29 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.2M | 89.3M |
| IPO Year | N/A | 2019 |
| Metric | NRXP | RFM |
|---|---|---|
| Price | $3.73 | $14.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $38.25 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 11.3K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,547.84 | N/A |
| Revenue Next Year | $1,591.73 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.65 | $13.68 |
| 52 Week High | $5.06 | $14.90 |
| Indicator | NRXP | RFM |
|---|---|---|
| Relative Strength Index (RSI) | 48.47 | 55.92 |
| Support Level | $3.45 | $14.22 |
| Resistance Level | $3.84 | $14.69 |
| Average True Range (ATR) | 0.32 | 0.11 |
| MACD | -0.09 | -0.00 |
| Stochastic Oscillator | 45.00 | 71.21 |
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.